In the pharmaceutical business<span>, the </span>long-run<span> challenge of drug innovation </span>is that the<span> key phrase throughout R&D that refers to increasing the output of original drug candidate molecules. T</span>o extend<span> R&D productivity, implementation </span>of recent<span> and strategic R&D orientations to develop new approaches or systems </span>to spot<span> hits and leads </span>expeditiously<span> has taken place and enabled all scientists </span>operating within the<span> drug discovery domain to develop innovative medicines for the </span>twenty-first<span> century.</span>
